Completed NA INTERVENTIONAL 1-arm NCT03797131

Clinical Food Study to Evaluate the Effect of KB195 on Gut Nitrogen Metabolism in Patients With Urea Cycle Disorders

An Open Label Pilot Study to Evaluate the Effect of KB195, a Novel Prebiotic Gluco-Oligosaccharide Mixture, in the Diet of Patients With Urea Cycle Disorders on Gut Nitrogen Metabolism

Sponsor: Kaleido Biosciences

Conditions Urea Cycle Disorders

Interventions KB195 (a novel mixture of oligosaccharides)

Updated 9 times since 2019 Last updated: Jan 8, 2020 Started: Jan 6, 2019 Primary completion: Sep 1, 2019 Completion: Sep 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Urea Cycle Disorders, this trial is completed. The trial is conducted by Kaleido Biosciences and has accumulated 9 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 4 earlier versions

Oct 2019 — Feb 2020 [monthly]

Recruiting NA
Apr 2019 — Oct 2019 [monthly]

Recruiting NA
Mar 2019 — Apr 2019 [monthly]

Recruiting NA
Feb 2019 — Mar 2019 [monthly]

Recruiting NA

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaleido Biosciences

Data source: Kaleido Biosciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland